Pharmaceuticals by one-year price change
How far the share price has moved over the last 52 weeks.
Erasca leads the 61 pharmaceuticals ranked by one-year price change, at +403%, ahead of Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%). Figures as of 18 Nov 2026, 14:51 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Erasca+403%
- Median
- +26.9%
- Combined market value
- ZAR 88.17T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | 1 year ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | ErascaERAS · Health Care | +403% | ZAR 81B | ZAR 230.77 | 3.38% down | 403% up | ||
| 2 | Spyre TherapeuticsSYRE · Health Care | +286% | ZAR 154.3B | ZAR 1,625.18 | 0.75% up | 286% up | ||
| 3 | Oruka TherapeuticsORKA · Health Care | +241% | ZAR 113.6B | ZAR 1,675.05 | 1.13% up | 241% up | ||
| 4 | VeradermicsMANE · Health Care | +233% | ZAR 91.8B | ZAR 2,176.14 | 0.72% up | 233% up | ||
| 5 | Definium TherapeuticsDFTX · Health Care | +169% | ZAR 68.9B | ZAR 503.15 | 0.41% down | 169% up | ||
| 6 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | +126% | ZAR 130.7B | ZAR 1,663.53 | 1.71% up | 126% up | ||
| 7 | Dianthus TherapeuticsDNTH · Health Care | +113% | ZAR 83.9B | ZAR 1,489.59 | 0.41% down | 113% up | ||
| 8 | TG TherapeuticsTGTX · Health Care | +107% | ZAR 163.1B | ZAR 1,079.39 | 0.10% up | 107% up | ||
| 9 | ViatrisVTRS · Health Care | +95.5% | ZAR 404.5B | ZAR 352.80 | 0.32% up | 96% up | ||
| 10 | Roivant SciencesROIV · Health Care | +90.3% | ZAR 480.9B | ZAR 663.76 | 0.28% down | 90% up | ||
| 11 | Edgewise TherapeuticsEWTX · Health Care | +88.2% | ZAR 77.2B | ZAR 705.55 | 2.40% down | 88% up | ||
| 12 | Amneal PharmaceuticalsAMRX · Health Care | +83.3% | ZAR 126.9B | ZAR 364.21 | 0.28% up | 83% up | ||
| 13 | Royalty PharmaRPRX · Health Care | +77.7% | ZAR 678B | ZAR 1,179.12 | 0.16% down | 78% up | ||
| 14 | Teva Pharmaceutical IndustriesTEVA · Health Care | +74.4% | ZAR 858.5B | ZAR 735.73 | 0.41% up | 74% up | ||
| 15 | GenmabGMAB · Health Care | +70.0% | ZAR 548.2B | ZAR 889.03 | 0.50% down | 70% up | ||
| 16 | Praxis Precision MedicinesPRAX · Health Care | +61.1% | ZAR 146.5B | ZAR 5,240.88 | 0.09% down | 61% up | ||
| 17 | AlkermesALKS · Health Care | +58.4% | ZAR 133.5B | ZAR 794.28 | 1.63% up | 58% up | ||
| 18 | Takeda PharmaceuticalTAK · Health Care | +53.6% | ZAR 1.18T | ZAR 369.88 | 0.62% down | 54% up | ||
| 19 | Merck & CoMRK · Health Care | +50.8% | ZAR 5.96T | ZAR 2,417.57 | 1.94% down | 51% up | ||
| 20 | Protagonist TherapeuticsPTGX · Health Care | +46.4% | ZAR 139.3B | ZAR 2,134.18 | 0.45% down | 46% up | ||
| 21 | Travere TherapeuticsTVTX · Health Care | +44.2% | ZAR 83.1B | ZAR 865.47 | 1.51% down | 44% up | ||
| 22 | Ligand PharmaceuticalsLGND · Health Care | +42.6% | ZAR 101B | ZAR 5,050.61 | 0.03% down | 43% up | ||
| 23 | Johnson & JohnsonJNJ · Health Care | +37.6% | ZAR 11.47T | ZAR 4,764.30 | 0.59% down | 38% up | ||
| 24 | Jazz PharmaceuticalsJAZZ · Health Care | +36.7% | ZAR 265.8B | ZAR 4,141.16 | 0.05% up | 37% up | ||
| 25 | Regeneron PharmaceuticalsREGN · Health Care | +36.3% | ZAR 1.71T | ZAR 16,532.65 | 0.38% up | 36% up | ||
| 26 | Eli LillyLLY · Health Care | +34.9% | ZAR 21.61T | ZAR 24,258.43 | 0.34% down | 35% up | ||
| 27 | Bristol-Myers SquibbBMY · Health Care | +34.0% | ZAR 2.13T | ZAR 1,042.59 | 1.22% down | 34% up | ||
| 28 | Belite BioBLTE · Health Care | +31.0% | ZAR 111B | ZAR 2,734.15 | 0.81% up | 31% up | ||
| 29 | Mirum PharmaceuticalsMIRM · Health Care | +30.5% | ZAR 103.3B | ZAR 1,581.76 | 0.04% up | 31% up | ||
| 30 | Ascendis PharmaASND · Health Care | +27.8% | ZAR 302B | ZAR 4,604.03 | 1.27% down | 28% up | ||
| 31 | Vertex PharmaceuticalsVRTX · Health Care | +26.9% | ZAR 2.34T | ZAR 9,228.95 | 0.47% up | 27% up | ||
| 32 | AbbVieABBV · Health Care | +25.7% | ZAR 8.83T | ZAR 4,993.86 | 0.84% down | 26% up | ||
| 33 | NovartisNVS · Health Care | +25.0% | ZAR 5.11T | ZAR 2,704.23 | 1.18% down | 25% up | ||
| 34 | United TherapeuticsUTHR · Health Care | +22.6% | ZAR 425.3B | ZAR 9,985.32 | 0.59% down | 23% up | ||
| 35 | Elanco Animal HealthELAN · Health Care | +20.5% | ZAR 224.4B | ZAR 448.98 | 1.01% up | 20% up | ||
| 36 | BridgeBio PharmaBBIO · Health Care | +17.2% | ZAR 256.4B | ZAR 1,316.09 | 0.35% down | 17% up | ||
| 37 | BeOne MedicinesONC · Health Care | +16.8% | ZAR 799B | ZAR 6,994.95 | 1.57% down | 17% up | ||
| 38 | PfizerPFE · Health Care | +14.4% | ZAR 2.78T | ZAR 486.90 | 0.54% down | 14% up | ||
| 39 | Rhythm PharmaceuticalsRYTM · Health Care | +13.0% | ZAR 137B | ZAR 1,975.98 | 1.46% down | 13% up | ||
| 40 | BioMarin PharmaceuticalBMRN · Health Care | +11.3% | ZAR 195.5B | ZAR 1,009.40 | 0.32% up | 11% up | ||
| 41 | Arrowhead PharmaceuticalsARWR · Health Care | +10.3% | ZAR 104.2B | ZAR 737.10 | 0.29% down | 10% up | ||
| 42 | GSKGSK · Health Care | +6.26% | ZAR 1.7T | ZAR 846.55 | 0.02% down | 6% up | ||
| 43 | Dr. Reddy's LaboratoriesRDY · Health Care | +5.27% | ZAR 214.5B | ZAR 257.25 | 1.15% up | 5% up | ||
| 44 | AstraZenecaAZN · Health Care | +2.41% | ZAR 4.81T | ZAR 3,102.66 | 0.98% down | 2% up | ||
| 45 | GrifolsGRFS · Health Care | +1.41% | ZAR 101.2B | ZAR 148.74 | 0.23% up | 1% up | ||
| 46 | SanofiSNY · Health Care | -4.08% | ZAR 1.96T | ZAR 817.49 | 0.02% up | 4% down | ||
| 47 | Axsome TherapeuticsAXSM · Health Care | -7.37% | ZAR 121.4B | ZAR 2,308.72 | 1.24% down | 7% down | ||
| 48 | Corcept TherapeuticsCORT · Health Care | -7.92% | ZAR 130.5B | ZAR 1,192.28 | 1.05% down | 8% down | ||
| 49 | Novo NordiskNVO · Health Care | -16.9% | ZAR 3.04T | ZAR 689.90 | 1.43% down | 17% down | ||
| 50 | Abbott LaboratoriesABT · Health Care | -17.0% | ZAR 3.12T | ZAR 1,801.44 | 0.00% | 17% down | ||
| 51 | PTC TherapeuticsPTCT · Health Care | -20.2% | ZAR 86.2B | ZAR 1,032.27 | 0.55% down | 20% down | ||
| 52 | CytokineticsCYTK · Health Care | -20.3% | ZAR 124.3B | ZAR 892.30 | 0.46% up | 20% down | ||
| 53 | Cogent BiosciencesCOGT · Health Care | -20.3% | ZAR 84.5B | ZAR 485.82 | 1.44% up | 20% down | ||
| 54 | Madrigal PharmaceuticalsMDGL · Health Care | -24.0% | ZAR 166B | ZAR 7,147.86 | 1.50% down | 24% down | ||
| 55 | ABIVAXABVX · Health Care | -27.3% | ZAR 125.6B | ZAR 1,434.57 | 1.61% up | 27% down | ||
| 56 | ZoetisZTS · Health Care | -28.7% | ZAR 589B | ZAR 1,449.61 | 0.98% up | 29% down | ||
| 57 | Summit TherapeuticsSMMT · Health Care | -35.6% | ZAR 147.6B | ZAR 184.51 | 0.56% up | 36% down | ||
| 58 | InsmedINSM · Health Care | -40.1% | ZAR 457.3B | ZAR 2,084.49 | 0.53% down | 40% down | ||
| 59 | Legend BiotechLEGN · Health Care | -42.5% | ZAR 55.1B | ZAR 284.01 | 2.52% up | 42% down | ||
| 60 | Ionis PharmaceuticalsIONS · Health Care | -63.6% | ZAR 77.5B | ZAR 465.61 | 0.43% up | 64% down | ||
| 61 | Alnylam PharmaceuticalsALNY · Health Care | -66.0% | ZAR 356B | ZAR 2,657.80 | 1.24% down | 66% down |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 17.1959 ZAR).
Questions and answers
Which pharmaceuticals rank first by one-year price change?
Erasca (+403%), Spyre Therapeutics (+286%) and Oruka Therapeutics (+241%) are the top three of the 61 pharmaceuticals ranked by one-year price change as of 18 Nov 2026, 14:51 UTC.
How many pharmaceuticals are in this ranking?
61 are ranked by one-year price change.
What are these pharmaceuticals worth together?
The 61 pharmaceuticals ranked by one-year price change have a combined market value of ZAR 88.17T as of 18 Nov 2026, 14:51 UTC.
What does ranking by one-year price change measure?
How far the share price has moved over the last 52 weeks.
Learn how this ranking works
All markets guides →- 52-week high and low: what the range tells you
A stock's 52-week high and low are the highest and lowest prices it reached over the past year. Where today's price sits in that range, from 0% at the low to 100% at the high, shows how the past year has gone. Sources differ on whether they use closing or intraday prices, so the same stock's range can differ slightly.
- Drawdown and recovery: why a 50% fall needs a 100% gain
A drawdown is how far a price has fallen from its previous peak, as a percentage of that peak. Recovery needs a larger gain than the fall, because the gain starts from a smaller base: a 20% drop needs a 25% rise to get back, a 50% drop needs 100%, and a 75% drop needs 300%.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Pharmaceuticals by one-year price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=year-change
Underlying data: Yahoo Finance; SEC EDGAR.